Total Payments
$2,465
2024 Payments
$340.70
Companies
12
Transactions
38
Medicare Patients
5,005
Medicare Billing
$520,732
Payment Breakdown by Category
Food & Beverage$2,338 (94.8%)
Other$127.27 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,338 | 37 | 94.8% |
| Honoraria | $127.27 | 1 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $547.29 | 5 | $0 (2021) |
| Genentech USA, Inc. | $474.65 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $388.92 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $350.19 | 4 | $0 (2019) |
| Alimera Sciences, Inc. | $334.12 | 7 | $0 (2024) |
| NotalVision | $127.27 | 1 | $0 (2017) |
| Spark Therapeutics, Inc. | $93.33 | 1 | $0 (2019) |
| Dutch Ophthalmic, USA | $52.05 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $43.69 | 2 | $0 (2023) |
| EyePoint Pharmaceuticals US, Inc. | $21.15 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $340.70 | 5 | Genentech USA, Inc. ($198.85) |
| 2023 | $177.46 | 5 | Alimera Sciences, Inc. ($94.00) |
| 2022 | $359.84 | 8 | Genentech USA, Inc. ($181.03) |
| 2021 | $352.01 | 5 | Allergan, Inc. ($186.16) |
| 2020 | $21.29 | 1 | Alimera Sciences, Inc. ($21.29) |
| 2019 | $735.18 | 8 | Novartis Pharmaceuticals Corporation ($303.40) |
| 2018 | $351.11 | 5 | Allergan Inc. ($236.13) |
| 2017 | $127.27 | 1 | NotalVision ($127.27) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $148.51 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/26/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $141.85 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 01/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/22/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/11/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $22.56 | General |
| 12/05/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $21.13 | General |
| 11/14/2023 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $94.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/20/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/13/2023 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 10/26/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $118.87 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/14/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/29/2022 | Carl Zeiss Meditec USA, Inc. | CLARUS (Device) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Fundus Camera | ||||||
| 09/23/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $20.42 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/16/2022 | Genentech USA, Inc. | SUSVIMO (Drug), VABYSMO | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/25/2022 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/21/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $125.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/21/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/10/2021 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $134.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/09/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $118.51 | General |
| Category: RETINA | ||||||
| 09/21/2021 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $67.65 | General |
| Category: RETINA | ||||||
| 04/20/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $15.91 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/15/2021 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Ophthalmology | ||||||
| 08/17/2020 | Alimera Sciences, Inc. | Iluvien (Drug) | Food and Beverage | Cash or cash equivalent | $21.29 | General |
| Category: Ophthalmology | ||||||
| 12/03/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RETINA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,234 | 2,363 | $476,856 | $101,322 |
| 2022 | 11 | 1,341 | 2,408 | $539,171 | $120,724 |
| 2021 | 13 | 1,301 | 2,031 | $438,034 | $105,253 |
| 2020 | 15 | 1,129 | 1,853 | $886,499 | $193,433 |
Total Patients
5,005
Total Services
8,655
Medicare Billing
$520,732
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67028 | Injection of drug into eye | Office | 2023 | 134 | 550 | $233,101 | $39,858 | 17.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 342 | 489 | $74,134 | $24,980 | 33.7% |
| 92134 | Imaging of retina | Office | 2023 | 415 | 951 | $89,918 | $16,467 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $17,965 | $6,350 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 60 | $10,432 | $4,160 | 39.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 85 | 104 | $27,554 | $2,901 | 10.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 49 | 49 | $8,116 | $2,687 | 33.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,840 | $1,486 | 30.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 21 | 27 | $2,941 | $1,043 | 35.5% |
| 66990 | Exam of eye using an endoscope | Facility | 2023 | 12 | 12 | $2,612 | $793.32 | 30.4% |
| 92250 | Photography of the retina | Office | 2023 | 20 | 22 | $3,008 | $307.61 | 10.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 12 | 15 | $2,235 | $288.96 | 12.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 120 | 503 | $232,141 | $38,221 | 16.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 366 | 503 | $58,195 | $25,887 | 44.5% |
| 92134 | Imaging of retina | Office | 2022 | 412 | 930 | $73,425 | $16,188 | 22.0% |
| 67039 | Destruction of eye fluid (vitreous) between lens and retina using a laser | Office | 2022 | 14 | 14 | $43,967 | $9,151 | 20.8% |
| 67039 | Destruction of eye fluid (vitreous) between lens and retina using a laser | Facility | 2022 | 13 | 13 | $41,437 | $8,823 | 21.3% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 106 | 106 | $13,705 | $6,396 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 79 | $12,459 | $5,483 | 44.0% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 13 | 19 | $14,592 | $3,960 | 27.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 72 | 80 | $25,894 | $2,419 | 9.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,326 | $2,139 | 40.2% |
| 92250 | Photography of the retina | Office | 2022 | 110 | 122 | $15,705 | $1,706 | 10.9% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 16 | 17 | $2,325 | $352.55 | 15.2% |
| 67028 | Injection of drug into eye | Office | 2021 | 106 | 415 | $184,442 | $30,684 | 16.6% |
About Dr. Radwan Ajlan, M.D
Dr. Radwan Ajlan, M.D is a Ophthalmology healthcare provider based in Kansas City, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1528476389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Radwan Ajlan, M.D has received a total of $2,465 in payments from pharmaceutical and medical device companies, with $340.70 received in 2024. These payments were reported across 38 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,338).
As a Medicare-enrolled provider, Ajlan has provided services to 5,005 Medicare beneficiaries, totaling 8,655 services with total Medicare billing of $520,732. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Kansas City, KS
- Active Since 07/24/2014
- Last Updated 12/19/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528476389
Products in Payments
- OZURDEX (Drug) $547.29
- EYLEA (Biological) $372.78
- Vabysmo (Drug) $217.47
- VABYSMO (Drug) $166.05
- YUTIQ (Drug) $163.00
- ILUVIEN (Drug) $152.68
- ForeseeHome (Device) $127.27
- BEOVU (Drug) $107.70
- LUXTURNA (Biological) $93.33
- Lucentis (Biological) $76.15
- EVA Ophthalmic Surgical System (Device) $52.05
- BROLUCIZUMAB (Drug) $46.79
- Iluvien (Drug) $39.59
- CLARUS (Device) $17.17
- EYLEA AFLIBERCEPT INJECTION (Biological) $16.14
- Constellation (Device) $15.03
- SUSVIMO (Drug) $14.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Kansas City
Steven Silverstein, Md, MD
Ophthalmology — Payments: $985,094
Ophthalmology $985,094
Dr. Joseph Tauber, M.d, M.D
Ophthalmology — Payments: $270,535
Ophthalmology $270,535
Stephen Wiles, Md, MD
Ophthalmology — Payments: $11,692
Ophthalmology $11,692
Abraham Park, Md, MD
Ophthalmology — Payments: $11,594
Ophthalmology $11,594
Dr. Michelle Boyce, Md, MD
Ophthalmology — Payments: $9,434
Ophthalmology $9,434
Dr. Lindsey Mcdaniel, M.d, M.D
Ophthalmology — Payments: $5,304
Ophthalmology $5,304